At its February meeting, EMA's safety committee, the #PRAC, started a safety review of medicines containing pseudoephedrine.
#PublicHealth #SafetyOfMedicines
➡️ https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-february-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1624037832950939650
A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.